Study links historical education policies to better cognitive outcomes later in life

Historical policies shaping educational attainment have enduring benefits for later life memory and risk of dementia, according to a study led by a Rutgers Health researcher.

Bristol Myers gets regulatory clearance to close Mirati deal as FTC increases pressure on pharma M&A

Bristol Myers Squibb has the go-ahead from antitrust regulators to complete its $4.8 billion takeover of Mirati. Increased FTC scrutiny has put large pharma mergers

December 21, 2023

Risk adjusted net present value: What is the current valuation of Eli Lilly and Co’s LY-3972406?

LY-3972406 is a small molecule commercialized by Eli Lilly and Co, with a leading Phase II program in Plaque Psoriasis (Psoriasis Vulgaris).

April 17, 2024

Year in Review: COVID-19

This year’s headlines on COVID-19 featured new research on COVID-related mortality, post-acute sequelae of infection, vaccine safety, and potential therapeutics. COVID Deaths Are Down, but…

November 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.